SEC Form 4 · accession 0001280776-16-000016
IMMUNIC, INC. · IMUX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Faheem Hasnain
Director
Period of report
Aug 11, 2016
Accepted (ET)
Aug 15, 2016 · 9:23 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280776
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 12, 2016 | P | 118,243 | $5.92 | A | 122,743 | D | |
| Common Stock | holding | — | — | — | 3,500 | I | By trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.92 | Aug 11, 2016 | A | 58,574 | A | — | Aug 10, 2026 | Common Stock | 58,574 | 58,574 | D |
Explanation of responses
- F1Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through each vesting date, 1/48th of the shares subject to the option shall vest and become exercisable monthly such that 100% of the shares subject to the option shall be fully vested and exercisable on August 11, 2020.